BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
2 hedge funds and large institutions have $30K invested in BIMI International Medical Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
114% more capital invested
Capital invested by funds: $14K → $30K (+$16K)
100% more funds holding
Funds holding: 1 → 2 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$24.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.65K |
BIMI Hedge Fund Activity: Q3 2014 in Review
2 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q3 2014, worth a combined $30K — up 114% from $14K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIMI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS, opening a new position worth an estimated $24.4K. The largest seller was Tower Research Capital (TRC), cutting an estimated $9.65K.
- 2 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q3 2014, up from 1 in Q2 2014.
- Funds reported $30K of BIMI International Medical Inc. Common Stock stock for Q3 2014, up 114% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q3 2014 was UBS, an estimated $24.4K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q3 2014 was Tower Research Capital (TRC), an estimated $9.65K sold.
Based on aggregated 13F filings for Q3 2014.